1991•PubMedRequires access

Baclofen in trigeminal neuralgia--a clinical trial.

Brajesh Parmar, Kirit Shah, Indravadan Gandhi

Abstract

Baclofen is a new antineuralgic drug. A clinical trial with treatment by this drug on 20 patients of trigeminal neuralgia was done. The action of this drug is similar to that of carbamazepine, however the former gives less undesirable side-effects. Out of 20 patients under treatment by this drug, 45% were relieved completely from pain while in 20% intensity and/or number of attacks of pain was reduced to half and in 35% effectiveness of Baclofen could not be observed.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Trigeminal neuralgia, Baclofen, Carbamazepine, Medicine, Drug, Anesthesia, Neuralgia, Clinical trial